Free Trial

Fresenius Medical Care (FMS) Stock Price, News & Analysis

Fresenius Medical Care logo
$28.35 -0.30 (-1.05%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$28.38 +0.04 (+0.12%)
As of 05/30/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fresenius Medical Care Stock (NYSE:FMS)

Key Stats

Today's Range
$28.11
$28.56
50-Day Range
$22.53
$29.88
52-Week Range
$17.93
$30.46
Volume
709,289 shs
Average Volume
331,530 shs
Market Capitalization
$16.64 billion
P/E Ratio
23.43
Dividend Yield
1.94%
Price Target
$27.80
Consensus Rating
Hold

Company Overview

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

FMS MarketRank™: 

Fresenius Medical Care scored higher than 55% of companies evaluated by MarketBeat, and ranked 490th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius Medical Care has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Fresenius Medical Care has only been the subject of 2 research reports in the past 90 days.

  • Read more about Fresenius Medical Care's stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius Medical Care are expected to grow by 27.15% in the coming year, from $1.51 to $1.92 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius Medical Care is 23.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius Medical Care is 23.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.03.

  • Price to Earnings Growth Ratio

    Fresenius Medical Care has a PEG Ratio of 0.76. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Fresenius Medical Care has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Fresenius Medical Care's valuation and earnings.
  • Percentage of Shares Shorted

    0.44% of the float of Fresenius Medical Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Fresenius Medical Care has recently increased by 274.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Fresenius Medical Care pays a meaningful dividend of 1.89%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius Medical Care does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius Medical Care is 49.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius Medical Care will have a dividend payout ratio of 28.65% next year. This indicates that Fresenius Medical Care will be able to sustain or increase its dividend.

  • Read more about Fresenius Medical Care's dividend.
  • Percentage of Shares Shorted

    0.44% of the float of Fresenius Medical Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Fresenius Medical Care has recently increased by 274.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Fresenius Medical Care has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Fresenius Medical Care this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Fresenius Medical Care to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

What is Zacks Research's Estimate for FMS Q2 Earnings?
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Equities Analysts Set Expectations for FMS Q3 Earnings
See More Headlines

FMS Stock Analysis - Frequently Asked Questions

Fresenius Medical Care's stock was trading at $22.64 at the beginning of the year. Since then, FMS stock has increased by 25.2% and is now trading at $28.35.
View the best growth stocks for 2025 here
.

Fresenius Medical Care AG (NYSE:FMS) posted its earnings results on Tuesday, May, 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The business had revenue of $5.54 billion for the quarter, compared to analyst estimates of $4.71 billion. Fresenius Medical Care had a net margin of 3.43% and a trailing twelve-month return on equity of 6.04%.
Read the conference call transcript
.

Fresenius Medical Care subsidiaries include NxStage Medical.

Fresenius Medical Care's top institutional shareholders include Pzena Investment Management LLC (2.62%), Fiduciary Management Inc. WI (1.01%), Millennium Management LLC (0.18%) and Goldman Sachs Group Inc. (0.12%).

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
5/06/2025
Record date for 6/6 Dividend
5/23/2025
Ex-Dividend for 6/6 Dividend
5/23/2025
Today
5/31/2025
Dividend Payable
6/06/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
NYSE:FMS
Employees
123,200
Year Founded
1912

Price Target and Rating

Average Stock Price Target
$27.80
High Stock Price Target
$30.00
Low Stock Price Target
$25.60
Potential Upside/Downside
-1.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
23.43
Forward P/E Ratio
18.77
P/E Growth
0.76
Net Income
$540.07 million
Pretax Margin
6.35%

Debt

Sales & Book Value

Annual Sales
$19.49 billion
Cash Flow
$5.72 per share
Price / Cash Flow
4.96
Book Value
$27.34 per share
Price / Book
1.04

Miscellaneous

Free Float
N/A
Market Cap
$16.64 billion
Optionable
Optionable
Beta
0.85

Social Links

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:FMS) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners